The Foundation for Clinical Research in Inflammatory Bowel Disease announces that it will present Advances in IBD sessions this fall in Grand Rapids, Cleveland, New Orleans and Memphis.

To register for any of these programs, please e-mail
register@myibd.org.

____________

October 21, 2008
Grand Rapids, Michigan

Hilton Grand Rapids Airport
4747 28th Street SE
Grand Rapids, MI 49504
Free Parking

Faculty:

Mark R. Fleisher, MD
Director Immune Mediated Inflammatory Disorders Clinic
Director of Infusion Therapy Clinic
Borland-Groover Clinic

John Papp Sr., MD
Clinical Professor
Michigan State University

____________

October 23, 2008
Cleveland, Ohio

Cleveland Airport Marriott
4277 West 150th Street
Cleveland OH 44135
Free Parking

Faculty:

Douglas C. Wolf, M.D.
Atlanta Gastroenterology Associates
Emory University School of Medicine

Aaron Brzezinski, MD
Division of GI
The Cleveland Clinic

Marsha Kay, MD, FAAP, FASGE, FACG
Section Head, Pediatric Endoscopy
The Cleveland Clinic

____________

November 11, 2008
New Orleans, Louisiana

Hilton New Orleans Airport
901 Airline Drive
Kenner, LA 70062
Free Parking

Faculty:

Kimberly Persley, MD
Clinical Assistant Professor
University of Texas Southwestern Medical School
Presbyterian Hospital

Allan J. Rosenberg, MD, MPH
Louisiana State University Health Science Center School of Medicine at New Orleans
Children's Hospital of New Orleans, Ambulatory Care Center

James W. Smith, MD
Director, Academic Affairs
Department of GI & Hepatology
Ochsner Health System
Past President
Ochsner Clinic Foundation

____________

November 13, 2008
Memphis, Tennessee

Hilton Memphis
939 Ridge Lake Bolevard
Memphis, TN 38120
Free Parking

Faculty:

David T. Rubin, MD, FACG
Associate Professor of Medicine
Program Director, Fellowship in Gastroenterology, Hepatology and Nutrition
Co-Director, Inflammatory Bowel Disease Center
University of Chicago Medical Center

David D. Sloas, MD
Gastroenterology Center of the Midsouth

Gene L. Whitington, MD
Clinical Professor of Pediatrics
The University of Tennessee Health Science Center
Memphis Pediatric Gastroenterology

____________

Advances in Inflammatory Bowel Disease is a free patient education program for anyone affected by Crohn's disease or ulcerative colitis.

Seminars are held throughout the U.S. and feature national and local experts in inflammatory bowel disease (IBD) who discuss the latest information on medical and surgical treatment options.

Patients in Hartford, Conn., learn from Dr. Joshua Korzenik of the Harvard University School of Medicine at an Advances in IBD seminar sponsored by the Foundation for Clinical Research in IBD.

In addition to learning about managing IBD and its complications, participants are invited to ask questions and receive a package of helpful materials.

The value of these seminars was assessed in a study conducted by Hude Quan, M.D., Ph.D., Lloyd R. Sutherland, M.D., and Jane W. Present, Department of Community Health Services, University of Calgary, Canada. Between March 2000 and December 2001, seminar participants from nine communities were asked to fill out a series of questionnaires. The results showed that the seminars not only improve participants’ knowledge of IBD but that participants retain the knowledge they acquire during the seminars.

Armed with up-to-date and accurate information, patients such as these are better able to become active participants in their healthcare.

A full report of the study appeared in the November 2003 issue of the peer-reviewed journal, “Inflammatory Bowel Diseases.”

Click on the links below to read transcripts from the 2005 “Advances in IBD” seminars.

Charlotte, NC
Providence, RI
Boston, MA

Click here to access the slide deck prepared to accompany the above programs (The slides may take a few moments to open, please be patient).

Click here to read a transcript of the 2004 “Advances in IBD” seminars.

This program is supported by unrestricted educational grants from Procter & Gamble Pharmaceuticals, Shire USA, Salix Pharmaceuticals, Axcan Pharma, Abbott Laboratories, UCB, Inc., and Elan Pharmaceuticals and held in conjunction with the Foundation for Clinical Research in Inflammatory Bowel Disease in association with HealthTalk.